QualityStocksNewsBreaks – INmune Bio Inc. (NASDAQ: INMB) Featured by M-Vest
INmune Bio (NASDAQ: INMB), focused on developing treatments that target the innate immune system to fight disease, was recently highlighted as a featured company by M-Vest. The business description reads, “Drug candidates, INKmune(TM) and INB03, may be used to treat cancer. XPro1595 targets neuroinflammation as a cause of Alzheimer’s disease. INmune Bio’s product platforms utilize … Continue reading “QualityStocksNewsBreaks – INmune Bio Inc. (NASDAQ: INMB) Featured by M-Vest”